Literature DB >> 32727298

Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts.

Per G Djupesland1, John C Messina2, Ramy A Mahmoud2.   

Abstract

Background: Nasal casts may characterize intranasal drug deposition. Methodology: The Koken cast, described as 'anatomically correct', and the Optinose cast, derived from MRI of a healthy male during velum closure, were dimensionally compared and assessed for deposition assessment suitability.
Results: Smallest vertical cross-sectional areas (valve region) for Koken and Optinose right/left: 2.55/2.75 and 1.18/1.18 cm2, respectively, versus a 'normative' mean (range) of 0.85 cm2 (0.2-1.6 cm2). Intranasal volumes differed (computed tomography/water fill): Koken, 35.8/38.6 cm3 and Optinose, 24.1/25.0 cm3, versus a 'normative' mean (range) of 26.4 cm3 (20.9-31.1 cm3).
Conclusion: Koken cast dimensions are larger than the normal range and the Optinose cast. The validity of casts for regulatory drug deposition studies is suspect.

Entities:  

Keywords:  devices; in vitro; nasal; targeting organ

Year:  2020        PMID: 32727298     DOI: 10.4155/tde-2020-0054

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  4 in total

1.  Importance of Spray-Wall Interaction and Post-Deposition Liquid Motion in the Transport and Delivery of Pharmaceutical Nasal Sprays.

Authors:  Arun V Kolanjiyil; Ali Alfaifi; Ghali Aladwani; Laleh Golshahi; Worth Longest
Journal:  Pharmaceutics       Date:  2022-04-28       Impact factor: 6.525

2.  A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose.

Authors:  Tair Lapidot; Mohammed Bouhajib; Janice Faulknor; Shabaz Khan; Galia Temtsin Krayz; Carolina Abrutzky; Dalia Megiddo
Journal:  Pharm Res       Date:  2022-04-06       Impact factor: 4.580

Review 3.  In Vitro Anatomical Models for Nasal Drug Delivery.

Authors:  Gerallt Williams; Julie D Suman
Journal:  Pharmaceutics       Date:  2022-06-26       Impact factor: 6.525

4.  A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies.

Authors:  Laura Nižić Nodilo; Ivo Ugrina; Drago Špoljarić; Daniela Amidžić Klarić; Cvijeta Jakobušić Brala; Mirna Perkušić; Ivan Pepić; Jasmina Lovrić; Vesna Saršon; Maša Safundžić Kučuk; Dijana Zadravec; Livije Kalogjera; Anita Hafner
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.